MarketsStocksDPL
DP

Dipna Pharmachem Ltd

NSE: DPL BSE: 543594Healthcare
Download Research Report7-page PDF
7.00
-0.28%
NSE · auto-updates while market open
Mkt Cap
-
P / E
-
P / B
-
ROE
-
52W High
₹25.66
52W Low
₹6.66
Key Metrics
Market Cap
-
P / E
-
P / B
-
EV / EBITDA
-
ROCE
-
ROE
-
Debt / Equity
-
Book Value
-
EPS
₹0.41
Div Yield
0.0%
Face Value
₹10
Promoter Holding
9.1%
Revenue · ₹ Cr
100
FY23
164
FY24
125
FY25
Net Profit · ₹ Cr
0
FY23
0
FY24
0
FY25
EPS · ₹ per share
₹0.8
FY23
₹0.9
FY24
₹0.4
FY25
Cash Flow Trend · ₹ Cr
−21
−21
FY23
−5
−5
FY24
−9
−9
FY25
Operating cash flowFree cash flow (CFO − capex)
Scorecard · 7 axes
Quality
-
Valuation
-
Growth
-
Profitability
-
Performance
Bad
-67.6%
Entry Point
Strong
27%
Red Flags
Strong
0 flags
Shareholding Pattern
9.1%Promoter
Promoter9.1%
Public90.9%
AlertPre-trade